Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Elkayam

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
ERJ Open Research|February 11, 2025
Cough frequency has a high daily variation in patients with chronic coughAlyn Morice, Mitja Alge, Laura Kuett, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 18, 2022
Review of evidence supporting the use of nasal corticosteroid irrigation for chronic rhinosinusitisJonathan A Bernstein, Andrew A White, Joseph K Han, et al.
The Journal of Allergy and Clinical Immunology|June 22, 2018
NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposisDonald A Leopold, David Elkayam, John C Messina, et al.
Journal of Clinical Immunology|March 7, 2012
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiencyRichard L Wasserman, Joseph A Church, Mark Stein, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
ERJ Open Research|February 11, 2025
Cough frequency has a high daily variation in patients with chronic coughAlyn Morice, Mitja Alge, Laura Kuett, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 18, 2022
Review of evidence supporting the use of nasal corticosteroid irrigation for chronic rhinosinusitisJonathan A Bernstein, Andrew A White, Joseph K Han, et al.
The Journal of Allergy and Clinical Immunology|June 22, 2018
NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposisDonald A Leopold, David Elkayam, John C Messina, et al.
Journal of Clinical Immunology|March 7, 2012
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiencyRichard L Wasserman, Joseph A Church, Mark Stein, et al.
Pageof 1